Cytopathology and More | Endometrial cells in Pap tests—when are they significant?

Create PDF

1. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23–47.
2. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
3. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212–236.
4. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114–2119.
5. Ng AB. The cellular detection of endometrial carcinoma and its precursors. Gynecol Oncol. 1974;2(2-3):162–179.
6. Burk JR, Lehman HF, Wolf FS. Inadequacy of papanicolaou smears in the detection of endometrial cancer. N Engl J Med. 1974;291:191–192.
7. Ng AB, Reagan JW, Hawliczek S, et al. Significance of endometrial cells in the detection of endometrial carcinoma and its precursors. Acta Cytol. 1974;18:356–361.
8. Gondos B, King EB. Significance of endometrial cells in cervicovaginal smears. Ann Clin Lab Sci. 1977;7:486–490.
9. Gusberg SB, Milano C. Detection of endometrial cancer and its precursors. Cancer. 1981;47(5 suppl):1173–1175.
10. Papillo JL. Who is teaching teens about HPV? Diagn Cytopathol. 2002;26:128–129.
11. Bean SM, Connolly K, Roberson J, et al. Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: the impact of the 2001 Bethesda System. Cancer. 2006;108:39–44.
12. Thrall MJ, Kjeldahl KS, Savik K, et al. Significance of benign endometrial cells in papanicolaou tests from women aged >or=40 years. Cancer. 2005;105:207–216.
13. Vooijs GP, van der Graaf Y, Vooijs MA. The presence of endometrial cells in cervical smears in relation to the day of the menstrual cycle and the method of contraception. Acta Cytol. 1987;31:427–433.
14. Liu W, Barrow MJ, Spitler MF, et al. Normal exfoliation of endometrial cells in premenopausal women. Acta Cytol. 1963;7:211–214.
15. Fadare O, Ghofrani M, Chacho MS, et al. The significance of benign endometrial cells in cervicovaginal smears. Adv Anat Pathol. 2005;12:274–287.
16. Canfell K, Kang YJ, Clements M, et al. Normal endometrial cells in cervical cytology: systematic review of prevalence and relation to significant endometrial pathology. J Med Screen. 2008;15:188–198.
17. Aslan DL, Crapanzano JP, Harshan M, et al. The Bethesda System 2001 recommendation for reporting of benign appearing endometrial cells in Pap tests of women age 40 years and older leads to unwarranted surveillance when followed without clinical qualifiers. Gynecol Oncol. 2007;107:86–93.
18. Koss LG, Melamed MR. Koss’ Diagnostic Cytology and Its Histopathologic Bases. 5th ed. Philadelphia, Pa.: Lippincott Williams & Wilkins; 2005.
19. Cibas ES, Ducatman BS. Cytology: Diagnostic Principles and Clinical Correlates. 3rd ed. Philadelphia, Pa.: Saunders Elsevier; 2009.
20. Ng AB, Reagan JW, Cechner RL. The precursors of endometrial cancer: a study of their cellular manifestations. Acta Cytol. 1973;17:437–448.
21. Greenspan DL, Cardillo M, Davey DD, et al. Endometrial cells in cervical cytology: review of cytological features and clinical assessment. J Low Genit Tract Dis. 2006;10:111–122.
22. Simsir A, Carter W, Elgert P, et al. Reporting endometrial cells in women 40 years and older: assessing the clinical usefulness of Bethesda 2001. Am J Clin Pathol. 2005;123:571–575.
23. Ashfaq R, Sharma S, Dulley T, et al. Clinical relevance of benign endometrial cells in postmenopausal women. Diagn Cytopathol. 2001;25:235–238.
24. Chang A, Sandweiss L, Bose S. Cytologically benign endometrial cells in the papanicolaou smears of postmenopausal women. Gynecol Oncol. 2001;80:37–43.
25. Beal HN, Stone J, Beckmann MJ, et al. Endometrial cells identified in cervical cytology in women > or = 40 years of age: criteria for appropriate endometrial evaluation. Am J Obstet Gynecol. 2007;196:568.e1–5.
26. Kapali M, Agaram NP, Dabbs D, et al. Routine endometrial sampling of asymptomatic premenopausal women shedding normal endometrial cells in Papanicolaou tests is not cost effective. Cancer. 2007;111:26–33.
27. Moroney JW, Zahn CM, Heaton RB, et al. Normal endometrial cells in liquid-based cervical cytology specimens in women aged 40 or older. Gynecol Oncol. 2007;105:672–676.
28. Siebers AG, Verbeek AL, Massuger LF, et al. Normal appearing endometrial cells in cervical smears of asymptomatic postmenopausal women have predictive value for significant endometrial pathology. Int J Gynecol Cancer. 2006;16(3):1069–1074.
29. Gomez-Fernandez CR, Ganjei-Azar P, Capote-Sishaw J, et al. Reporting normal endometrial cells in Pap smears: an outcome appraisal. Gynecol Oncol. 1999;74:381–384.
30. Li Z, Gilbert C, Yang H, et al. Histologic follow-up in patients with Papanicolaou test findings of endometrial cells: results from a large academic women’s hospital laboratory. Am J Clin Pathol. 2012;138:79–84.
31. Cherkis RC, Patten S, Dickinson JC, et al. Significance of atypical endometrial cells detected by cervical cytology. Obstet Gynecol. 1987;69:786–789.
32. Zhou J, Tomashefski J Jr, Khiyami A. Diagnostic value of the thin-layer, liquid-based Pap test in endometrial cancer: a retrospective study with emphasis on cytomorphologic features. Acta Cytol. 2007;51:735–741.
33. Van den Bosch T, Vandendael A, Wranz PA, et al. Cervical cytology in menopausal women at high risk for endometrial disease. Eur J Cancer Prev. 1998;7:149–152.

Dr. Zhao is a professor of pathology and associate director of cytopathology, and Dr. Li is a cytopathology fellow, Department of Pathology, Magee-Womens Hospital, University of Pittsburgh Medical Center. Dr. Zhao is a member of the CAP Cytopathology Committee.